Comparisons of tumor biopsy samples obtained prior to and during tazemetostat revealed a substantial increase in intra-tumoral and stromal infiltrates of CD8+ cytotoxic and FOXP3+ regulatory T cells, together with an enhanced expression of the PD-1 and LAG3 immune-checkpoint proteins on T cells. This evidence concerns the gene CD8A and neoplasm.